Pharmaceuticals could be key to success in Doha

Solving the differences between developing countries and the US over Trade Related Intellectual Property Rights (TRIPS) and pharmaceuticals could be the key to launching a new round of trade negotiations in Doha. The commitment of developing countries to reaching a satisfactory agreement on this issue offers hope for flexibility on their part in other areas.